Cardiometabolic Outcomes in Transgender Youth

J Clin Endocrinol Metab. 2022 Nov 25;107(12):e4380-e4381. doi: 10.1210/clinem/dgac592.

Authors

Michele A O'Connell^{1

2

3}, Ken C Pang^{1

2

3}

Affiliations

¹ Department of Adolescent Medicine, The Royal Children's Hospital, Parkville, Victoria, 3052, Australia.
² Clinical Sciences, Murdoch Children's Research Institute, Parkville, Victoria, 3052, Australia.
³ Department of Paediatrics, University of Melbourne, Parkville, Victoria, 3052, Australia.

PMID: 36221797
DOI: 10.1210/clinem/dgac592

No abstract available

Keywords: adolescents; cardiovascular risk; gender diverse; hormone therapy; transgender.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Adolescent
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / etiology
Gender Identity
Humans
Transgender Persons*
Transsexualism*

Grants and funding